secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001140361-24-033343
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis adds risk factor on off-label Aquadex use in neonates under 20 kg
--------------------------------------------------------------------------

- Aquadex System cleared only for patients ≥20 kg, but is being modified for neonates/kidney failure infants.
- FDA may view company communications as off-label promotion, risking untitled letters, fines, or criminal penalties.
- Off-label promotion could trigger False Claims Act lawsuits, exclusion from Medicare/Medicaid, and corporate integrity agreements.
- Updated corporate presentation posted on IR website; no specific financial or strategic changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036124033343/0001140361-24-033343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036124033343/ef20032513_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-033343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer